Useful Resources

 

About Us

In this website, you can find the latest articles and
information about diagnosis, treatment and
definitions of Heart diseases or cardiology.
You can ask your questions online through
the contact form on this website and we will
respond them after a while.

Articles by Sections

Translator

How to Develop a Heart Failure Management Pathway PDF Print E-mail
Written by Administrator   
Monday, 22 February 2010 23:24


Despite advances in pharmaceuticals and technology, heart failure (HF) continues to be a large health-related economic burden. Numerous programs and systems have been implemented over the years in an attempt to decrease the cost and length of hospital stay involved in the care of patients with HF. Disease-based guidelines have helped to incorporate evidence-based practices into the care of HF patients. An instrument that has been put into practice to improve efficiency in using those guidelines is clinical-based pathways that define and organize the processes involved in patient care management.1–5

CLINICAL MANAGEMENT PATHWAYS

development in a timely manner.6 The medical field began using clinical management pathways in the 1980s when nurses developed them to structure patient care processes within a designated timeframe.7 This was in response to the government’s prospective payment system of diagnostic related grouping (DRG), which was implemented in 1983. With DRGs, payment for hospitalization is limited to a predetermined length of stay (LOS) based on the patient’s diagnosis. This has led to an increased emphasis on containing costs in health care without sacrificing the quality of patient care.8 HF disease management programs, multidisciplinary clinics, case management, observation units, patient telemanagement, and clinical pathways are multiple strategies that have been developed in attempts to reduce HF costs.9

Practice guidelines originated in the 1950s and Clinical management pathways, also known as were used by the industry to coordinate project critical pathways, caremaps, and integrated care pathways, are designed to be used in conjunction with the present standard of care as a tool to decrease variation in outcomes and maintain care within a specified LOS. They facilitate clinical interventions by guiding the patient’s hospitalization through a sequence of steps toward a desired outcome. Clinical pathways are generally applied to high-volume diagnoses or procedures and those with longer LOS and mortality, such as HF, myocardial infarction, coronary artery bypass grafting, hip surgery, or vascular surgery. These procedures tend to have a predictable course of events during the hospitalization and marked variation in care.10 Pathways are designed to be integrated management plans that improve clinical outcomes, resource usage, coordination and quality of care, and discharge process. With the use of clinical pathways, clinical performance variation is decreased and hospital LOS and related costs are reduced.8,11,12 The content of clinical pathways designates the major interventions and patient outcomes, and is based on expert guidelines, current standards, and published clinical trials.13

CLINICAL PATHWAY DEVELOPMENT

Clinical pathway development has historically been initiated by nursing, but in many institutions this led to lack of physician commitment.10 Incorporating a multidisciplinary team to evaluate current practice and collect clinical data for development of the clinical pathway is the best way to begin the process and encourage involvement from nonnursing disciplines (Fig. 19-1).14 Traditionally, a physician leader or “champion” heads the committee, contributing leadership and clinical expertise. The team may consist of physicians (cardiologists, emergency room physicians, internists), nurses, nurse practitioners, administrators, quality improvement (QI) committee members, case managers, and members from social services, nutrition, cardiac rehabilitation, respiratory therapy, and pharmacy.

A retrospective chart review of financial data, LOS, readmission data, mortality, and direct costs for HF admissions will more than likely illuminate the need for a clinical pathway to guide inpatient HF management within a designated timeframe. A literature review of current data on HF pathways and standards of care for HF provides the groundwork for developing a template. Clinical goals must be defined before developing the clinical pathway. The committee should set objectives and goals to include clinical outcomes measurement, Joint Commission on Accreditation of Healthcare Organizations (JCAHO) compliance, patient satisfaction, and clinical pathway monitoring.11 The goals must be translated into elements of care in a sequence of events and expected patient progress over a designated timeframe.12 To accomplish this, frequent team meetings are required. The format for a clinical pathway may range from a simple checklist to detailed steps for the process of care. Standardized admission and discharge orders may coincide with the pathway and provide a solid foundation to support the interventions on the pathway (App. 19-A).

Prior to implementation of the pathway, educational in-services on content of the pathway and QI concepts are provided to those involved with the care of HF patients. The physician leader presents the pathway to appropriate physicians at medical grand rounds and/or through memos. An HF nurse or advanced practice nurse in-services the inpatient staff, and patients receive a copy of their own pathway. The nursing staff provides education on the pathway to the patient and their family. Pathways should identify an accountable person to ensure that clinical outcomes are met in a timely fashion.15

Multidisciplinary roles within the pathway must be clearly defined as to those responsible for documenting information, analyzing data, and educating the patient and family. Variances are the patient outcomes or staff actions that do not meet the expectation of the pathway or do not occur within the designated timeframe. These variances should be tracked throughout the process of using and developing the pathway, in order to define areas that need improvement. Piloting of the pathway is necessary for analysis, by the HF nurses. Printed educational materials a quarterly basis.13 A chart audit may also be are given to the patient and their family, and other used as part of the QI process to ensure that HF audiovisual learning tools may be used, such as patient care adheres to the clinical pathway.16 videotapes, heart models, or computer web-Identification of variances and evaluation of based programs. A longer, more detailed educa-clinical indicators can lead to improvement in tion session for the patient and family may take the process of managing patient care (Table 19-1). place in the outpatient setting. Consults along the The pathway content is updated by yearly evalpathway are specific to the patient’s needs, but uation of patient variances and LOS, as well as may include cardiac rehabilitation, nutrition, and reviewing current clinical practice for the spesmoking cessation. Diagnostic tests are specified cific diagnosis or procedure. as to when they should be performed during the hospitalization. HF medications may be listed on the pathway as outlined in national guidelines for BARRIERS TO CLINICAL HF care. Dietary guidelines and activity level PATHWAYS advance as appropriate along the pathway.

Comprehensive hospital-specific perfor-Some health-care professionals feel that clinical mance and benchmarking reports about pathways are time-consuming and “cookbook processes and outcomes of care are gathered by medicine,” applicable to only the “ideal,” not the the QI committee and presented to the team on complex patient. One large barrier to using a clinical pathway is a lack of voluntary participation among key individuals. The additional paperwork involved in tracking outcomes and data regarding use of the pathway is seen as a burden to some health-care workers, but these documents may be used as a QI tool, and may serve to fulfill regulatory requirements. The paper format may affect the ability to effectively evaluate variances, link clinical processes with patient outcomes, and see real-time benefits.17 Absence of documentation can lead to pathway discontinuity and inaccurate data. Continued education, frequent communication, and sharing of outcome data encourage participation with the pathway. Cost savings should be evaluated, and the information shared with the multidisciplinary team and hospital administrators. Automated pathways may be created to coincide with electronic medical record charting and to query outcome data in a more timely fashion.

BENEFITS OF A HEART FAILURE CLINICAL PATHWAY

Pathways have been shown to decrease LOS and resource consumption.8 They may help to define the patient care roles and responsibilities of health-care professionals, improve integration and communication in the health-care system, develop learning processes within an organization, reduce inpatient mortality, and improve patient clinical outcomes. They support risk management, utilization management, and the evaluation that is necessary for growth and improvement in any setting. Pathways can assist with documentation and validation of the desired outcomes.12

Clinical pathways address the complex needs of HF patients and are designed to increase the use of appropriate medications, consults, and education. Consumers may find clinical management pathways attractive due to better service, improved communication from providers, and superior outcomes. This information can be used as a marketing tool by health-care institutions. Increased patient satisfaction is related to a decrease in medical lawsuits, and in most cases, a patient’s decision to sue results from weak attitudes or inferior communication skills by providers.18

Goals to be achieved by using a clinical pathway include decreasing, LOS, readmissions, and emergency rooms visits; documenting left ventricular dysfunction; prescribing appropriate medications; initiating nutrition consults; and scheduling a follow-up appointment with the HF team or the patient’s health-care provider 1–2 weeks following discharge. Periodic review of pathways allows an opportunity to incorporate new advances in medical care and may provide a source of continuous medical education for providers.7

OUTCOMES RELATED TO CLINICAL PATHWAYS

Preventing medical errors contributes to cost savings in health care and enhances patient outcomes. It is estimated that between 44,000 and 98,000 patients die annually due to medical errors in the United States.19 Reducing variations in care practices by standardizing the patient’s clinical path may be an effective tool to reduce the probability of medical errors.
The high cost of health care has necessitated the adoption of cost-effective approaches in patient management. As an interdisciplinary instrument, clinical pathways move the patient care process through a sequence of clinical interventions toward desired outcomes (Table 19-2). These outcomes may include cost-efficient care and reduced variations in patient management.

Numerous authors have reported improved outcomes after the application of a clinical pathway for the management of HF patients. Cordoza and Aherns analyzed the use of a clinical pathway, looking at LOS, cost of care, mortality data, readmission statistics, and performance rates of care processes in a group of elderly HF patients admitted to the hospital.8 They compared a random sample of hospitalized HF patients receiving usual care to a group of HF patients who were managed on a clinical pathway. There was a significant reduction in the LOS, variable cost, and readmission rate in the patients managed with the clinical pathway compared to the patients receiving usual care without a pathway. Mortality rate during hospitalization remained unchanged. Several processes of patient care were significantly improved among the patients on the clinical pathway, including early initiation of discharge planning, early mobilization of patients’ activity, and providing basic HF education to patients. Additionally, documentation of daily weights, heparin prescription, and echocardiography were improved. Importantly, patients on the clinical pathway had more effective diuresis per patient than those who were not managed with a clinical pathway.

After implementation of a clinical pathway for HF patients Panella et al. reported a decrease in total hospital admissions, inpatient mortality, and LOS.12 They also found a significant improvement in some predetermined quality indicators, such as left ventricular assessment, smoking cessation counseling, discharge instructions, and completion of clinical documentation. They did not, however, find a decrease in costs after implementing the pathway.

Ranjan et al. developed and implemented a clinical pathway for patients with HF in order to decrease hospital charges and maintain efficiency and quality of care.20 After 2 years of using the pathway, they evaluated the effectiveness of the program. They found that LOS was reduced to under 4 days in 65% of the pathway patients compared to 42% of patients who were not using a clinical pathway. Hospital charges were significantly reduced, and use of angiotensin-converting enzyme inhibitors was greater in the patients on the clinical pathway. These improved outcomes held true for patients who had 2–4 comorbidities, and even in complicated patients with 5 or more comorbidities. The authors were able to demonstrate that duality of care was not compromised by reduced length of hospital stay in patients on the clinical pathway.

Several authors have reported improved outcomes in HF disease management programs in which the clinical pathway was only one component. Knox and Mischke described a program that incorporated inpatient education, an inpatient HF clinical pathway, an outpatient clinic, and cardiac home care using a home care clinical pathway.14 They reported a 50% decrease in direct inpatient costs and a decrease in the LOS to 4 days, compared with 6.2 days before implementing the program. Quality indicators also improved, such as documentation of daily weights, frequency of dietary consultation, documentation of left ventricular function, appropriate medication use, and scheduling follow-up care. Rauh et al. also reported improved outcomes after implementing an inpatient and outpatient HF program that utilized a clinical pathway.21 They demonstrated a reduction in LOS, reduced 90-day readmission rate, and significantly reduced inpatient costs.

Not all authors have reported positive outcomes after implementing a clinical pathway for HF patients. Philbin et al. did not find statistically significant improvement in five quality-of-care markers after initiating a clinical pathway for the management of HF patients.13 The etiology of HF and prescription of angiotensin-converting enzyme inhibitors was improved slightly, but documentation of left ventricular systolic function was reduced. Hospital LOS and hospital charges were not significantly reduced. The effects on mortality, hospital readmission, and quality of life after discharge were not significant.

CLINICAL PATHWAYS IN THE OUTPATIENT SETTING

Clinical pathways can be useful in the outpatient setting, either in an outpatient clinic or in the home health setting. Standards of care for the management of chronic HF are clearly delineated and can easily be incorporated into a pathway (App. 19-C). Outpatient clinical management pathways can be useful to ensure that standards of care are followed by all providers, particularly those who do not specialize in HF management, such as primary care practices.

Hoskins et al. compared two groups of elderly home health patients with HF. An outpatient clinical pathway guided care in one group of patients, while the other group was given “usual” home health care.22 They reported a 45% reduction in the rehospitalization rate among patients whose care was guided by a clinical pathway compared to patients who were not managed on a pathway.

SUMMARY

Over the last 20 years, there has been increasing emphasis on containing costs without compromising the quality of patient care. QI includes the use of clinical management pathways and disease management programs, and has improved patient outcomes.13 Clinical management pathways are an overall QI plan to meet specific patient population needs in all settings, particularly HF. The use of clinical management pathways allows patients to receive better care through an organized method that coordinates the clinical processes and reduces variations in patient care practices.

REFERENCES

1. Massie B, Shah N. Evolving trends in the epidemiologic factors of heart failure: rationale for preventive strategies and comprehensive disease management. Am Heart J. 1997;133:703–712.
2. American Heart Association. Heart Disease and Stroke Statistics: 2007 Update. Dallas, Texas: American Heart Association; 2007.
3. Koelling T, Chen R, Lubwama R, et al. The expanding national burden of heart failure in the United States: the influence of heart failure in women. Am Heart J. 2004;147:74–78.
4. O’Connell J, Bristow M. Economic impact of heart failure in the United States: time for a different approach. J Heart Lung Transplant. 1994;13:S107–S112.
5. DeFrances C, Hall M, Podgornik M. 2003 National Hospital Discharge Survey. Hyattsville, MD: U.S. Department of Health and Human Services; July 8, 2005.
6. Luttman J, Laffel G, Pearson S. Using program evaluation and review technique/critical path method to design and improve clinical processes. Qual Manag Health Care. 1995;3:1–13.
7. Cardozo L, Ahrens S, Steinberg J, et al. Implementing a clinical pathway for congestive heart failure: experiences at a teaching hospital. Qual Manag Health Care. 1998;7:1–12.
8. Cardozo L, Aherns S. Assessing the efficacy of a clinical pathway in the management of older patients hospitalized with congestive heart failure. J Healthc Qual. 1999;21:12–16.

 
Copyright © 2012 MolCardiology. All Rights Reserved.